TEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Teva Pharmaceutical Industries Ltd's quarterly accounts payable increased from Sep. 2013 ($3,049 Mil) to Dec. 2013 ($3,317 Mil) but then declined from Dec. 2013 ($3,317 Mil) to Mar. 2014 ($3,143 Mil).
Teva Pharmaceutical Industries Ltd's annual accounts payable declined from Dec. 2011 ($3,572 Mil) to Dec. 2012 ($3,376 Mil) and declined from Dec. 2012 ($3,376 Mil) to Dec. 2013 ($3,317 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Teva Pharmaceutical Industries Ltd Annual Data
Teva Pharmaceutical Industries Ltd Quarterly Data